Antimicrobial Resistance

NFID is committed to raising awareness and educating healthcare professionals about antibiotic resistant organisms and their impact on public health, as well as the implementation of antimicrobial stewardship programs including guidelines for prescribing antibiotics, systems to track the use of antibiotics, and protocols for proper hand hygiene, sanitation, and overall infection control.

NFID has partnered with Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID) to provide continuing medical education (CME) for antimicrobial stewardship education.

  • ABC’s of Antibiotics
    Association for Professionals in Infection Control and Epidemiology (APIC) handout to educate patients about the proper use of antibiotics and prevention of antibiotic resistance
  • Annual Conference on Antimicrobial Resistance
    NFID Conference Archives 2002-2010
  • Antibiotic/Antimicrobial Resistance
    Centers for Disease Control and Prevention (CDC)
  • Antibiotic Resistance Threats in the United States (2013)
    Centers for Disease Control and Prevention (CDC) report gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health
  • Antimicrobial Resistance: Global Report on Surveillance (2014)
    World Health Organization (WHO): This report provides, as accurate a picture as is presently possible of the magnitude of Antimicrobial Resistance (SMR) and the current state of surveillance globally. The report makes a clear case that resistance to common bacteria has reached alarming levels in many parts of the world and that in some settings, few, if any, of the available treatments options remain effective for common infections. Another important finding of the report is that surveillance of antibacterial resistance is neither coordinated nor harmonized and there are many gaps in information on bacteria of major public health importance.
  • Antimicrobial Stewardship Education and Training
    Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID) offers two training programs designed to teach the skills and provide an overview of antimicrobial stewardship practice needed to develop a stewardship program
  • Antimicrobial Stewardship Program for Pharmacists
    Society of Infectious Diseases Pharmacists (SIDP) certificate training program
  • Core Elements of Hospital Antibiotic Stewardship Programs (2014)
    Centers for Disease Control and Prevention (CDC): This document summarizes core elements of successful hospital Antibiotic Stewardship Programs (ASP). It complements existing guidelines on ASPs from organizations including the Infectious Diseases Society of America (IDSA) in conjunction with the Society for Healthcare Epidemiology of America (SHEA), American Society of Health System Pharmacists (ASHSP), and The Joint Commission
  • Drug Resistance
    World Health Organization (WHO)
  • Get Smart About Antibiotics
    Centers for Disease Control and Prevention (CDC) annual campaign focused on reducing the rate of rise of antibiotic resistance by: promoting adherence to appropriate prescribing guidelines among providers; decreasing demand for antibiotics for viral upper respiratory infections among healthy adults and parents of young children; and increasing adherence to prescribed antibiotics for upper respiratory infections
  • Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID)
    MAD-ID is a 501(c)3 non-profit organization which provides education, in the form of traditional continuing education, skills training, and other pertinent learning methods, to pharmacists, physicians, and other healthcare professionals in the areas of infectious diseases pharmacotherapy and antimicrobial stewardship
  • Special Report: Antimicrobial Resistance – Time for Change (2014)
    Medscape
  • The Evolving Threat of Antimicrobial Resistance-Options for Action (2012)
    World Health Organization (WHO) publication examines the experiences with interventions which address the growing threat of antimicrobial resistance, describes the lessons learnt along the way and highlights the gaps still remaining. It draws attention to areas where knowledge is lacking and where urgent action is still needed
  • Transatlantic Task Force on Antimicrobial Resistance (TATFAR)
    TATFAR was created in 2009 with the goal of improving cooperation between the US and EU in three key areas: appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities, prevention of healthcare and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs
  • US Stakeholder Forum on Antimicrobial Resistance (S-FAR)
    S-FAR is a new national partnership convened by the Infectious Diseases Society of America (IDSA)